SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-063162
Filing Date
2023-05-22
Accepted
2023-05-22 16:25:14
Documents
17
Period of Report
2023-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2316415d1_8k.htm   iXBRL 8-K 65377
2 EXHIBIT 2.1 tm2316415d1_ex2-1.htm EX-2.1 633466
3 EXHIBIT 10.1 tm2316415d1_ex10-1.htm EX-10.1 1629301
4 EXHIBIT 99.1 tm2316415d1_ex99-1.htm EX-99.1 147236
5 EXHIBIT 99.2 tm2316415d1_ex99-2.htm EX-99.2 44656
9 GRAPHIC tm23164151ex99-2img001.jpg GRAPHIC 28810
  Complete submission text file 0001104659-23-063162.txt   3240691

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA irwd-20230521.xsd EX-101.SCH 3051
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20230521_lab.xml EX-101.LAB 34476
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20230521_pre.xml EX-101.PRE 22607
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2316415d1_8k_htm.xml XML 3621
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 23944813
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences